Modern Diagnostic & Research Centre traded at Rs 96 on the BSE, a premium of 6.67% compared with the issue price of Rs 90.

GOING PUBLIC — Artificial intelligence giant Anthropic signed a term sheet Wednesday to raise $10 billion at a $350 billion ...

China's biotech revival is pushing up prices of laboratory monkeys used in drug testing, as renewed R&D activity collides ...

Learn about spinning in IPOs, including its significance and ethical implications. Explore historical examples like Goldman Sachs and eBay's Meg Whitman.

After months of frustration and sideways trading, investors in Baidu (NASDAQ: BIDU) finally have a tangible reason to be ...

Structure Therapeutics Inc. (NASDAQ:GPCR) is a clinical stage global biopharmaceutical company that develops and delivers ...

" Last year, we closed at around Rs 250 crore in revenue, with a 35%-plus CAGR year-on-year growth. With the IPO and ...

Modern Diagnostic and Research Centre's shares are poised for a steady debut on the BSE SME, with grey market premiums ...

Learn what SEC Form F-1 is, its necessary criteria for foreign companies on U.S. exchanges, and explore detailed real-world filing examples for practical insight.

There's an amazing opportunity to generate great returns for our investors. And there's also an amazing opportunity to lose a ...

The world tried to kill Andy off but he had to stay alive to to talk about what happened with databases in 2025.

As you can see, the SCHG is a highly-subscribed fund ($50+ billion in assets under management) and is very cost efficient ...